Human  	Human  	 JJ	O
liver  	liver  	 JJ	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes  	enzymes  	 NNS	O
influence  	influence  	 VBP	O
metabolic  	metabolic  	 JJ	B-NP
flux  	flux  	 NN	I-NP
via  	via  	 IN	O
branch  	branch  	 NN	O
points  	points  	 NNS	O
and  	and  	 CC	O
inhibitors  	inhibitors  	 JJ	O
Rate-limiting  	Rate-limiting  	 JJ	O
enzymes 	enzymes 	 NN	O
,  	,  	 ,	O
because  	because  	 IN	O
of  	of  	 IN	O
their  	their  	 PRP$	O
relatively  	relatively  	 RB	O
low  	low  	 JJ	O
velocity 	velocity 	 NN	B-NP
,  	,  	 ,	O
are  	are  	 VBP	O
believed  	believed  	 VBN	O
to  	to  	 TO	O
influence  	influence  	 VB	O
metabolic  	metabolic  	 JJ	B-NP
flux  	flux  	 NN	I-NP
in  	in  	 IN	O
pathways 	pathways 	 NN	O
.  	.  	 .	O
To  	To  	 TO	O
investigate  	investigate  	 VB	O
their  	their  	 PRP$	O
regulatory  	regulatory  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
metabolic  	metabolic  	 JJ	B-NP
networks 	networks 	 NNS	I-NP
,  	,  	 ,	O
we  	we  	 PRP	O
look  	look  	 VBP	O
at  	at  	 IN	O
the  	the  	 DT	O
global  	global  	 JJ	O
organization  	organization  	 NN	B-NP
and  	and  	 CC	O
interactions  	interactions  	 NNS	B-NP
between  	between  	 IN	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes  	enzymes  	 NN	O
and  	and  	 CC	O
compounds  	compounds  	 JJ	O
such  	such  	 JJ	O
as  	as  	 IN	O
branch  	branch  	 NN	B-NP
point  	point  	 NN	I-NP
metabolites  	metabolites  	 NNS	I-NP
and  	and  	 CC	O
enzyme  	enzyme  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
liver 	liver 	 NN	O
.  	.  	 .	O
Based  	Based  	 VBN	O
on  	on  	 IN	O
96  	96  	 CD	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes  	enzymes  	 NN	O
and  	and  	 CC	O
132  	132  	 CD	O
branch  	branch  	 NN	O
point  	point  	 NN	O
compounds  	compounds  	 NN	O
from  	from  	 IN	O
human  	human  	 JJ	O
liver 	liver 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
found  	found  	 VBD	O
that  	that  	 DT	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes  	enzymes  	 NNS	O
surrounded  	surrounded  	 VBN	O
76.5 	76.5 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
branch  	branch  	 NN	O
points 	points 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
compound  	compound  	 JJ	O
conversion  	conversion  	 NN	B-NP
network  	network  	 NN	I-NP
from  	from  	 IN	O
human  	human  	 JJ	O
liver 	liver 	 NN	O
,  	,  	 ,	O
the  	the  	 DT	O
128  	128  	 CD	O
branch  	branch  	 NN	O
points  	points  	 NNS	O
involved  	involved  	 VBN	O
showed  	showed  	 VBD	O
a  	a  	 DT	O
dramatically  	dramatically  	 RB	O
higher  	higher  	 RBR	O
average  	average  	 JJ	O
degree 	degree 	 NN	O
,  	,  	 ,	O
betweenness  	betweenness  	 JJ	B-NP
centrality  	centrality  	 NN	I-NP
and  	and  	 CC	O
closeness  	closeness  	 JJ	B-NP
centrality  	centrality  	 NN	I-NP
as  	as  	 IN	O
a  	a  	 DT	O
whole 	whole 	 NN	O
.  	.  	 .	O
Nearly  	Nearly  	 RB	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
inhibitors  	inhibitors  	 NN	I-NP
were  	were  	 VBD	O
products  	products  	 NNS	O
of  	of  	 IN	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes 	enzymes 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
covered  	covered  	 VBD	O
75.34 	75.34 	 CD	O
%  	%  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
inhibited  	inhibited  	 JJ	O
targets  	targets  	 NNS	O
in  	in  	 IN	O
metabolic  	metabolic  	 JJ	B-NP
inhibitory  	inhibitory  	 JJ	I-NP
networks 	networks 	 NNS	I-NP
.  	.  	 .	O
From  	From  	 IN	O
global  	global  	 JJ	O
topological  	topological  	 JJ	B-NP
organization 	organization 	 NN	I-NP
,  	,  	 ,	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes  	enzymes  	 NN	O
as  	as  	 IN	O
a  	a  	 DT	O
whole  	whole  	 JJ	O
surround  	surround  	 JJ	O
most  	most  	 JJS	O
of  	of  	 IN	O
the  	the  	 DT	O
branch  	branch  	 NN	O
points 	points 	 NNS	O
;  	;  	 :	O
so  	so  	 RB	O
they  	they  	 PRP	O
can  	can  	 MD	O
influence  	influence  	 VB	O
the  	the  	 DT	O
flux  	flux  	 NN	B-NP
through  	through  	 IN	O
branch  	branch  	 NN	O
points 	points 	 NNS	O
.  	.  	 .	O
Since  	Since  	 IN	O
nearly  	nearly  	 RB	O
half  	half  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
enzyme  	enzyme  	 JJ	I-NP
inhibitors  	inhibitors  	 NNS	I-NP
are  	are  	 VBP	O
produced  	produced  	 VBN	O
by  	by  	 IN	O
rate-limiting  	rate-limiting  	 JJ	O
enzymes  	enzymes  	 NN	O
in  	in  	 IN	O
human  	human  	 JJ	O
liver 	liver 	 NN	O
,  	,  	 ,	O
these  	these  	 DT	O
enzymes  	enzymes  	 NN	O
can  	can  	 MD	O
initiate  	initiate  	 VB	O
inhibitory  	inhibitory  	 JJ	B-NP
regulation  	regulation  	 NN	I-NP
and  	and  	 CC	O
then  	then  	 RB	O
influence  	influence  	 VB	O
metabolic  	metabolic  	 JJ	B-NP
flux  	flux  	 NN	I-NP
through  	through  	 IN	O
their  	their  	 PRP$	O
natural  	natural  	 JJ	O
products 	products 	 NNS	O
.  	.  	 .	O
